Literature DB >> 24220280

Frequency of aortic dilation in Noonan syndrome.

James W Cornwall1, Robert S Green2, James C Nielsen3, Bruce D Gelb4.   

Abstract

Noonan syndrome (NS) is a genetic disorder caused by mutations altering proteins relevant to RAS/mitogen-activated protein kinase signal transduction. Cardiac involvement is common, most prevalently pulmonary valve stenosis and hypertrophic cardiomyopathy. Because abnormal mitogen-activated protein kinase signaling contributes to the aortopathy in Marfan syndrome and with rare reports of aortic aneurysm in NS, we undertook a retrospective study of ascending aortic anatomy in 37 patients with NS and without confounding medical conditions. Age ranged from 0.6 to 32 years. Based on the most recent echocardiogram, the aortic annulus and root were dilated in the cohort (mean z scores of 1.14 and 0.98, respectively, p <0.005) but the sinotubular junction and ascending aorta were not (mean z scores of 0.05 and 0.19, respectively). The aortic root was aneurysmal (>2 z scores) in 8 subjects (21.6%). PTPN11 mutations were present in 14 subjects, whose aortic status was similar to the cohort overall. Comparison of age and z scores revealed a modest tendency for the aortic annulus and root to dilate over time. Among 13 subjects with multiple imaging studies over an average of 6.8 years, the average z score increased to 0.78 and 0.39 for the aortic annulus and root, respectively. Multivariate analysis revealed that age accounted for 7.0% and 11.0% of the variance in the aortic annular and root diameters, respectively. In conclusion, we found that aortic annular dilation and aortic root aneurysm are prevalent in NS, often presenting during childhood and progressing over time. Further study is needed to identify potential risks associated with these abnormalities.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24220280      PMCID: PMC3947366          DOI: 10.1016/j.amjcard.2013.09.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Two cases of Noonan syndrome: aortic coarctation causing a giant aneurysm of the descending aorta.

Authors:  Mustafa Paç; Ayşe Esin Kibar; Mehmet Burhan Oflaz; Feyza Ayşenur Paç
Journal:  Turk Kardiyol Dern Ars       Date:  2011-10

2.  Survival implications: hypertrophic cardiomyopathy in Noonan syndrome.

Authors:  Edward J Hickey; Rohit Mehta; Maryam Elmi; Kentaro Asoh; Brian W McCrindle; William G Williams; Cedric Manlhiot; Lee Benson
Journal:  Congenit Heart Dis       Date:  2011 Jan-Feb       Impact factor: 2.007

3.  Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal.

Authors:  B Marino; M C Digilio; A Toscano; A Giannotti; B Dallapiccola
Journal:  J Pediatr       Date:  1999-12       Impact factor: 4.406

Review 4.  Noonan syndrome and clinically related disorders.

Authors:  Marco Tartaglia; Bruce D Gelb; Martin Zenker
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-02       Impact factor: 4.690

5.  LEOPARD syndrome: a new polyaneurysm association and an update on the molecular genetics of the disease.

Authors:  Marineh Yagubyan; Jean M Panneton; Noralane M Lindor; Emanuela Conti; Anna Sarkozy; Antonio Pizzuti
Journal:  J Vasc Surg       Date:  2004-04       Impact factor: 4.268

6.  Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry.

Authors:  James D Wilkinson; April M Lowe; Bonnie A Salbert; Lynn A Sleeper; Steven D Colan; Gerald F Cox; Jeffrey A Towbin; David M Connuck; Jane E Messere; Steven E Lipshultz
Journal:  Am Heart J       Date:  2012-08-09       Impact factor: 4.749

7.  PTPN11 mutation associated with aortic dilation and hypertrophic cardiomyopathy in a pediatric patient with Noonan syndrome.

Authors:  John L Jefferies; John W Belmont; Ricardo Pignatelli; Jeffrey A Towbin; William J Craigen
Journal:  Pediatr Cardiol       Date:  2009-10-01       Impact factor: 1.655

8.  Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.

Authors:  Karen W Gripp; Elizabeth Hopkins; Katia Sol-Church; Deborah L Stabley; Marni E Axelrad; Daniel Doyle; William B Dobyns; Cindy Hudson; John Johnson; Romano Tenconi; Gail E Graham; Ana Berta Sousa; Raoul Heller; Maria Piccione; Giovanni Corsello; Gail E Herman; Marco Tartaglia; Angela E Lin
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

9.  Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.

Authors:  Jennifer P Habashi; Jefferson J Doyle; Tammy M Holm; Hamza Aziz; Florian Schoenhoff; Djahida Bedja; YiChun Chen; Alexandra N Modiri; Daniel P Judge; Harry C Dietz
Journal:  Science       Date:  2011-04-15       Impact factor: 47.728

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more
  5 in total

Review 1.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

2.  Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.

Authors:  Léa Linglart; Bruce D Gelb
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-02-05       Impact factor: 3.908

3.  Aortic dilation, genetic testing, and associated diagnoses.

Authors:  Yuri A Zarate; Elizabeth Sellars; Tiffany Lepard; Xinyu Tang; R Thomas Collins
Journal:  Genet Med       Date:  2015-07-02       Impact factor: 8.822

Review 4.  Genetic and Epigenetic Regulation of Aortic Aneurysms.

Authors:  Ha Won Kim; Brian K Stansfield
Journal:  Biomed Res Int       Date:  2017-01-01       Impact factor: 3.411

5.  Third reported patient with RAP1B-related syndromic thrombocytopenia and novel clinical findings.

Authors:  Dana Miller; Azhar Saeed; Andrew C Nelson; Matthew Bower; Anjali Aggarwal
Journal:  Am J Med Genet A       Date:  2022-04-22       Impact factor: 2.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.